SCHEMBL16624910

SCHEMBL16624910

CCCCCOC(=O)CC(c1ccccc1)C(C)C(=O)c1ccc(OC)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.46
LMNA P02545 4/20 0.46
GAA P10253 2/20 0.46
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
MAPT P10636 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
POLB P06746 1/20 0.44
TP53 P04637 2/20 0.43
TSHR P16473 1/20 0.43
PLA2G4B P0C869 2/20 0.43
MITF O75030 1/20 0.42
ALDH1A1 P00352 1/20 0.42
HIF1A Q16665 1/20 0.42
THRB P10828 1/20 0.42
GPR88 Q9GZN0 1/20 0.42
NPSR1 Q6W5P4 1/20 0.41
HTT P42858 1/20 0.41
RARB P10826 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16624914 0.91 SMN1; SMN2 (0.47) SMN1; SMN2LMNAGAANPC1RAB9A
SCHEMBL19071744 0.89 GAA (0.42) SMN1; SMN2LMNAGAANPC1RAB9A
SCHEMBL16624915 0.89 SMN1; SMN2 (0.44) SMN1; SMN2LMNAGAANPC1RAB9A
SCHEMBL16624912 0.87 NPSR1 (0.48) SMN1; SMN2LMNANPC1RAB9AMAPT
SCHEMBL16624903 0.86 MAPT (0.45) SMN1; SMN2LMNAGAANPC1RAB9A
SCHEMBL16624913 0.83 KCNA5 (0.52) SMN1; SMN2LMNANPC1RAB9AMAPT
SCHEMBL16624894 0.81 L3MBTL1 (0.63) SMN1; SMN2LMNANPC1RAB9AMAPT
SCHEMBL16624899 0.81 ALDH1A1 (0.54) SMN1; SMN2LMNANPC1RAB9AMAPT
SCHEMBL16624923 0.79 ALOX15 (0.44) SMN1; SMN2LMNAGAANPC1RAB9A
SCHEMBL16624924 0.78 ALDH1A1 (0.45) SMN1; SMN2LMNANPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2864284-B1 PHOTOLABILE PRO-FRAGRANCES HENKEL AG & CO KGAA (DE) 2017-07-05 EP disclosed
US-9458081-B2 Photolabile pro-fragrances HENKEL AG & CO. KGAA (DE) 2016-10-04 US disclosed
US-9458081-B2 Photolabile pro-fragrances HENKEL AG & CO. KGAA (DE) 2016-10-04 US disclosed
US-20150099809-A1 PHOTOLABILE PRO-FRAGRANCES HENKEL AG & CO. KGAA (DE) 2015-04-09 US disclosed
US-20150099809-A1 PHOTOLABILE PRO-FRAGRANCES HENKEL AG & CO. KGAA (DE) 2015-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150099809-A1 PHOTOLABILE PRO-FRAGRANCES TRPA1, PSAP, CRY1 SMN1; SMN2 2584/4885LMNA 1058/4885GAA 1977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.